Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Research article

Memory complaints and depressive symptoms over time: a construct-level replication analysis

Authors: Jacqueline Mogle, Nikki L. Hill, Sakshi Bhargava, Tyler Reed Bell, Iris Bhang

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Memory complaints and depressive symptoms are frequently associated in older adults and both serve as potential indicators of future cognitive decline. However, the temporal ordering of the development of these two symptoms remains unclear. The goal of the current study was to examine concurrent and temporal relationships between memory complaints and depressive symptoms in older adults.

Methods

Data were drawn from two longitudinal, nationally representative datasets and included cognitively intact older adults aged 65 and over. The datasets in the current study were from the National Health and Aging Trends Study (NHATS) and the Health and Retirement Study (HRS). Using an integrative analytic framework, we tested bidirectional temporal relationships between memory complaints (memory ratings and perceived memory decline) and depressive symptoms over 6 to 9 years of data in over 5000 older adults across these two samples.

Results

Across both datasets, perceived memory decline predicted future depressive symptoms whereas memory ratings did not. Additionally, results showed that at times when depressive symptoms tended to be higher, memory complaints were also higher, but depressive symptoms did not predict future memory complaints. One finding that was inconsistent across datasets was memory ratings predicting depressive symptoms. After accounting for covariates, this relationship was only significant in one dataset.

Conclusions

Cognitively intact older adults who report memory decline may be at risk for developing depressive symptoms in the future. Furthermore, our findings highlight the importance of using immediate replication of results across datasets to determine the generalizability of conclusions.
Appendix
Available only for authorised users
Literature
18.
26.
go back to reference Hox J. Multilevel analysis: techniques and applications. 2nd ed. New York: Routledge; 2010.CrossRef Hox J. Multilevel analysis: techniques and applications. 2nd ed. New York: Routledge; 2010.CrossRef
47.
go back to reference Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kȩdziora-Kornatowska K. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016. https://doi.org/10.12740/PP/45368.PubMedCrossRef Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kȩdziora-Kornatowska K. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016. https://​doi.​org/​10.​12740/​PP/​45368.PubMedCrossRef
Metadata
Title
Memory complaints and depressive symptoms over time: a construct-level replication analysis
Authors
Jacqueline Mogle
Nikki L. Hill
Sakshi Bhargava
Tyler Reed Bell
Iris Bhang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-1451-1

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine